--- title: "Profound Medical's Market Cap Drops To CA$227m Leaving Insiders With Losses" description: "Profound Medical Corp.'s market cap has fallen to CA$227 million, resulting in significant losses for insiders who invested US$1.01 million at an average price of US$7.87. The stock price has declined" type: "news" locale: "en" url: "https://longbridge.com/en/news/253309842.md" published_at: "2025-08-16T13:25:38.000Z" --- # Profound Medical's Market Cap Drops To CA$227m Leaving Insiders With Losses > Profound Medical Corp.'s market cap has fallen to CA$227 million, resulting in significant losses for insiders who invested US$1.01 million at an average price of US$7.87. The stock price has declined by 23%, reducing the value of their investment to US$766.4k. Despite this, insiders, including CEO Arun Menawat, have made recent purchases, indicating confidence in the company's future. Insiders own 8.1% of the company, valued at CA$18 million, suggesting alignment with shareholders. However, the company is facing losses and has warning signs that potential investors should consider. Insiders who acquired US$1.01m worth of **Profound Medical Corp.'s** (TSE:PRN) stock at an average price of US$7.87 in the past 12 months may be dismayed by the recent 23% price decline. Insiders buy with the expectation to see their investments rise in value over a period of time. However, recent losses have rendered their above investment worth US$766.4k which is not ideal. While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. ## The Last 12 Months Of Insider Transactions At Profound Medical The Chairman of the Board & CEO Arun Menawat made the biggest insider purchase in the last 12 months. That single transaction was for CA$212k worth of shares at a price of CA$10.62 each. So it's clear an insider wanted to buy, even at a higher price than the current share price (being CA$5.96). It's very possible they regret the purchase, but it's more likely they are bullish about the company. We always take careful note of the price insiders pay when purchasing shares. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. Profound Medical insiders may have bought shares in the last year, but they didn't sell any. They paid about CA$7.87 on average. These transactions suggest that insiders have considered the current price attractive. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below! See our latest analysis for Profound Medical There are always plenty of stocks that insiders are buying. If investing in lesser known companies is your style, you could take a look at this **free** list of companies. (Hint: insiders have been buying them). ## Profound Medical Insiders Bought Stock Recently There was some insider buying at Profound Medical over the last quarter. Independent Director Arthur L. Rosenthal purchased CA$51k worth of shares in that period. We like it when there are only buyers, and no sellers. But the amount invested in the last three months isn't enough for us too put much weight on it, as a single factor. ## Insider Ownership Of Profound Medical I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It appears that Profound Medical insiders own 8.1% of the company, worth about CA$18m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders. ## So What Does This Data Suggest About Profound Medical Insiders? The recent insider purchase is heartening. And the longer term insider transactions also give us confidence. But we don't feel the same about the fact the company is making losses. Given that insiders also own a fair bit of Profound Medical we think they are probably pretty confident of a bright future. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Every company has risks, and we've spotted **4 warning signs for Profound Medical** (of which 2 don't sit too well with us!) you should know about. But note: **Profound Medical may not be the best stock to buy**. So take a peek at this **free** list of interesting companies with high ROE and low debt. *For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.* ### Related Stocks - [PROF.US - Profound Medical](https://longbridge.com/en/quote/PROF.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Profound Medical Corp 慶祝在 PRO FAMILIA 完成第 500 例 Sonalleve®手術 | Profound Medical Corp 宣佈於 2026 年 2 月 5 日在波蘭的 PRO FAMILIA 完成其第 500 例 Sonalleve® 手術。這一里程碑突顯了非手術治療子宮疾病的日益普及，全球已有超過 4000 名女性 | [Link](https://longbridge.com/en/news/274979659.md) | | Profound Medical（TSE:PRN）創下 1 年新高 - 現在是買入的好時機嗎？ | Profound Medical（多倫多證券交易所代碼：PRN）在交易中達到了新的 52 周高點 C$12.40，收盤價為 C$11.85。該公司的市值為 C$4.21 億，市盈率為-8.79，報告的收入為 C$736 萬，預計本財年的每股 | [Link](https://longbridge.com/en/news/272465052.md) | | 貝森特和沃什的 “導師”，德魯肯米勒 Q4“精準” 開倉金融股 ETF、標普等權重 ETF 和巴西 ETF | 科技股方面，德魯肯米勒 Q4 清倉了 Meta，加倉了谷歌與 Sea。德魯肯米勒與貝森特、沃什的 “師徒” 關係讓市場推測，“德魯肯米勒經濟學”——即反赤字、反通脹、反關税——可能通過貝森特和沃什滲透至政策制定中。 | [Link](https://longbridge.com/en/news/276214511.md) | | 特斯拉首輛 Cybercab 下線：沒有方向盤和踏板的汽車終於來了 | 特斯拉宣佈，首輛賽博無人駕駛電動車 Tesla Cybercab 在美國得州超級工廠正式下線。風險提示及免責條款 市場有風險，投資需謹慎。本文不構成個人投資建議，也未考慮到個別用户特殊的投資目標、財務狀況或需要。用户應考慮本文中的任何意見、 | [Link](https://longbridge.com/en/news/276188665.md) | | 摩爾線程快速完成對 Qwen3.5 模型全面適配 | 摩爾線程宣佈已在旗艦級 AI 訓推一體全功能 GPU MTT S5000 上完成對阿里最新大模型 Qwen3.5 的全方位適配。此次支持充分展示了摩爾線程 MUSA 生態的成熟度與完備性，開發者可通過 MUSA C 編程語言及 Triton | [Link](https://longbridge.com/en/news/276153560.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.